Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UBT251 in Obese Participants With Moderate-to-severe Obstructive Sleep Apnea (OSA)
NCT07767942Phase 3Not yet recruiting
- Start
- Dec 2026
- Primary completion
- Sep 2028
01
Overview
A Phase 3 trial of UBT251 in obstructive sleep apnea (OSA), obesity. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
UBT251
03
Conditions
obstructive sleep apnea (OSA)obesity
Beyond the preview
Go deeper on NCT07767942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07767942.